LIVE

BCPC

Balchem Corp

BCPC

NASDAQ·Basic Materials·Chemicals - Specialty·Mkt cap $5.4B

$167.69

▼ -0.71%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$139.17 - $183.90

P/E

34.43

Fwd P/E

32.02

Beta

0.83

Div Yield

0.57%

Avg Vol

216.5K

Shares Out

32.0M

Mkt Cap

$5.4B

Price action

Price chart

Up 3.5% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Proprietary microencapsulation and chelation technology platforms with high barriers to entry
  • Diversified customer base across pharma, food, animal health, and medical device sterilization reduces concentration risk
  • Essential product applications in regulated industries create sticky, long-term customer relationships
  • Integrated manufacturing capabilities and supply chain control support margin expansion
▼

Bear Case

2 risks

  • Average volatility.
  • Significant premium - growth priced in

Growth

Stable outlook

Rising global demand for fortified foods and nutritional supplements driven by health-conscious consumers

Value

Significant premium - growth priced in

Momentum

Stable

-0.9% over 3m

Quality

Stable

Excellent business quality

Dividend

Modest

0.57% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 22, 2026

“
Q2 26 RECAP

APR 30, 2026

Reported EPS of $1.25 vs $1.41 consensus (-11.3% surprise). Revenue of $270.7M vs $266.5M expected (+1.6%).

EPS miss
Rev beat +1.6%

EPS surprise · last 4Q

0 of 1 beats

Q2 26

-11.3%

Next: Apr 22, 2026

Revenue trend · last 8Q

—

—

+5%

+5%

+9%

+12%

+10%

+8%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$234.1M

$239.9M

$240.0M

$250.5M

$255.5M

$267.6M

$263.6M

$270.7M

Margins · last 8Q

Gross

37.3%

Operating

20.5%

Profit

14.9%

View full earnings history →

Wall Street consensus

1 analyst · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

100%

Hold

0%

Sell

0%

Median Price Target

—

Latest: HC Wainwright · May 4, 2026

View full analyst page →

vs Industry

How BCPC stacks vs Chemicals - Specialty

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.